INBX
Inhibrx Biosciences, Inc.
100.30$
-9.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.9% | 89.5% | 56.7% | 58.7% | 92.0% | 92.5% | 96.4% | 95.9% | 88.7% | 90.7% | |
| 94.1% | 78.1% | 21.1% | 43.6% | 89.5% | 87.3% | 94.2% | 90.3% | 84.4% | 84.8% | |
| 94.1% | 78.1% | 21.1% | 43.6% | 89.5% | 87.3% | 94.2% | 90.3% | 84.4% | 84.8% | |
| – | 4.0% | 6.9% | 1.7% | 0.4% | 0.6% | 0.1% | 0.3% | 0.2% | 0.1% | |
| – | 5.8% | 23.1% | 12.1% | -89.9% | -0.6% | -0.1% | – | – | – | |
| 94.2% | 230.0% | 677.4% | 453.2% | 47.5% | 65.2% | 80.0% | 85.9% | 26.1% | 94.5% | |
| 24.8% | 51.7% | 162.1% | 77.7% | 21.8% | 14.9% | 9.5% | 18.3% | 22.5% | 23.1% | |
| 20.0% | 30.0% | 59.4% | 17.6% | 1.0% | 1.1% | 0.6% | 0.7% | 0.9% | 1.6% | |
| 0.8% | 4.5% | 65.4% | 11.8% | 9.4% | 6.1% | 2.9% | 3.6% | 5.1% | 4.1% | |
| – | – | – | – | – | – | – | 67.2% | – | 68.7% | |
| -43.5% | -166.8% | -577.4% | -353.2% | 52.5% | 34.8% | 20.0% | 14.1% | 73.9% | 5.5% | |
| -43.5% | -166.8% | -178.8% | -261.4% | -101.1% | -151.0% | -128.0% | -199.3% | -58.7% | -168.1% | |
| 171.8% | 166.9% | 271.2% | 138.0% | 17.6% | 25.3% | 13.8% | 15.3% | 8.0% | 10.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.